Brief Report: Should Abacavir Be a First-Line Alternative for Adults With HIV in Sub-Saharan Africa?

Domain:

healthcare

Record type:

paper

Creator:

GuiSuzYapPet

Publisher:

Ovi

Host:

Abstract: Despite a poor toxicity profile, zidovudine supersedes abacavir (ABC) as an alternative first-line agent in most international treatment guidelines because of concerns about HLA-B*57:01-related ABC-hypersensitivity. We detected one case of HLA-B*57:01 carriage among 513 HIV-infected individuals in Uganda, which, in combination with previous reports, supports the safety of ABC in the region.

Visit

doi.org

What Should be the Focus of Agricultural Policy Reforms in Sub-Saharan Africa? A CGE Analysis

While a lot of research has been conducted on agricultural subsidies and other forms of policy trans

Protease Inhibitor Resistance in the First 3 Years of Second-Line Antiretroviral Therapy for HIV-1 in Sub-Saharan Africa

Background.
As antiretroviral therapy (ART) programs in sub-Saharan Africa mature, increasing n

Screening tools for HIV-associated neurocognitive disorders among adults living with HIV in sub-Saharan Africa: A scoping review

Background : People living with HIV are at risk of developing HIV-associated ne

Perceptions of Social Support Sufficiency Among Older Adults With HIV in Sub-Saharan Africa

Abstract Globally, the greatest number of older people with HIV (OPWH) are in sub-S

Should Digital Interventions for HIV Self-Testing Be Regulated with World Health Organization Prequalification?

Abstract HIV self-testing (HIVST) allows people to test for HIV outside traditional heal

Brief Report: Stigma and HIV Care Continuum Outcomes Among Ethiopian Adults Initiating ART

Background: Stigma harms the mental health of HIV-positive individuals and reduces adh